We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU, FDA Question J&J Trials, Zeftera Withdrawn from Canada
EU, FDA Question J&J Trials, Zeftera Withdrawn from Canada
April 15, 2010
Canadian sales of Zeftera, Janssen-Ortho’s skin-infection treatment, are being halted after the EU and the FDA expressed concerns about the sponsor’s
conduct of clinical trials.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor